| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 16.34× | 16.34× | 54.09× | 59.48× | 27.19× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| −0.43× | −0.44× | −0.16× | −0.18× | −0.20× | ||
| 0.38× | 0.38× | 0.32× | 0.32× | 0.30× | ||
| 0.69× | 0.69× | −0.73× | −0.29× | −0.27× | ||
| 1.60× | 1.60× | 2.30× | 0.53× | 17.97× |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 27.19 | 59.48 | 54.09 | 16.34 | 16.34 | |
| Working Capital Turnover | -0.20 | -0.18 | -0.16 | -0.44 | -0.43 | |
| Asset Turnover | 0.30 | 0.32 | 0.32 | 0.38 | 0.38 | |
| Cash Conversion (CFO/Net Income) | -0.27 | -0.29 | -0.73 | 0.69 | 0.69 | |
| CFO/EBITDA | 17.97 | 0.53 | 2.30 | 1.60 | 1.60 |